The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / T•• F•••••••• G••••

A••••• C•••••• P••••••• Announces Investment in T•• F•••••••• G••••

Platform acquisitionannouncedannounced May 7, 2026Fact
What happened
Target
T•• F•••••••• G••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
Corporate parent
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
11 named
Buy side
  • S•• B•••••••Deal partnerconfirmed
    “S•• B•••••••, Principal at A••••• C•••••• P•••••••, commented: “As long-time, dedicated healthcare investors, supporting businesses and management teams that are expanding access to high-quality care is one of our core investment themes.”
  • A••••• C•••••• P•••••••• L•••Sponsorconfirmed
    “A••••• C•••••• P••••••• (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the acquisition of T•• F•••••••• G••••, one of the leading fertility care providers in the UK and Northern Europe, from B•••••• S••••• P••••••• (BSP) – a F”
Sell side
  • B•••••• S••••• P•••••••Sellerconfirmed
    “A••••• C•••••• P••••••• (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the acquisition of T•• F•••••••• G••••, one of the leading fertility care providers in the UK and Northern Europe, from B•••••• S••••• P••••••• (BSP) – a F”
  • B•••••• S••••• P•••••••Sellerconfirmed
    “A••••• C•••••• P••••••• (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the acquisition of T•• F•••••••• G••••, one of the leading fertility care providers in the UK and Northern Europe, from B•••••• S••••• P••••••• (BSP) – a F”
Advisory side
  • M•••••••• W••• • S•••••• L••Buy-side adviserconfirmed
    “A••••• was advised by L•••••• I••••••••• and M•••••••• W••• • S•••••• on the transaction.”
  • L•••••• I••••••••• L••Buy-side adviserconfirmed
    “A••••• was advised by L•••••• I••••••••• and M•••••••• W••• • S•••••• on the transaction.”
  • F••• A•••••Sell-side adviserconfirmed
    “BSP was advised by Rothschild & Co and L•••••••••.”
  • L•••••••••Sell-side adviserconfirmed
    “BSP was advised by Rothschild & Co and L•••••••••.”
Side not stated
  • J••• F••••••Managementconfirmed
    “J••• F••••••, Group Chief Executive Officer of TFP, said: “This is a significant milestone for TFP.”
  • J••• F••••••Managementconfirmed
    “J••• F••••••, Group Chief Executive Officer of TFP, said: “This is a significant milestone for TFP.”
  • T•• F•••••••• G••••Targetconfirmed
    “A••••• C•••••• P••••••• (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the acquisition of T•• F•••••••• G••••, one of the leading fertility care providers in the UK and Northern Europe, from B•••••• S••••• P••••••• (BSP) – a F”
Evidence
“A••••• C•••••• P••••••• (“A•••••”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the acquisition of T•• F•••••••• G••••, one of the leading fertility care providers in the UK and Northern Europe, from B•••••• S••••• P••••••• (BSP) – a Franklin Templeton company.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026